Therapeuticsmd Inc (TXMD)

Jun 26, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 24, 2026

TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 24, 2026

Jun 22, 2026

TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 22, 2026

Jun 22, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Jun 22, 2026

Jun 22, 2026

TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026

Jun 19, 2026

TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 19, 2026

Jun 18, 2026

TherapeuticsMD Inc (TXMD) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 18, 2026

TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jun 18, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates Amid Continued Cash BurnNet Income Trends - newsline.com

Jun 17, 2026

Jun 15, 2026

TherapeuticsMD (TXMD) Gains 3.64%, Tests Resistance at $2.39High Low Breadth - newsline.com

Jun 15, 2026

Jun 15, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 15, 2026

Jun 14, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates Sharply, Yet Stock Surges 20.9%EPS Surprise History - newsline.com

Jun 14, 2026

Jun 11, 2026

TXMD Q3 2023 Earnings: Wider-than-Expected Loss Highlights Operational ChallengesProfit Inflection Point - newsline.com

Jun 11, 2026

Jun 10, 2026

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jun 10, 2026

Jun 10, 2026

TherapeuticsMD (TXMD) Nears Support Amid Modest Selling PressureIndex Put Call - newsline.com

Jun 10, 2026

Jun 10, 2026

TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance ZoneAAII Neutral - newsline.com

Jun 10, 2026

Jun 08, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jun 08, 2026

Jun 04, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jun 04, 2026

Jun 02, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 02, 2026

May 29, 2026

TXMD Q3 2023 Earnings: Deep EPS Miss Overshadowed by Strategic ProgressNegative Surprise Momentum - newsline.com

May 29, 2026

May 29, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Amid Operational ChallengesTrough Earnings Signal - The Legal Advocate

May 29, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates, Stock DeclinesPost-Earnings Drift - newsline.com

May 27, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates by Wide Margin Amidst Operational Challenges - newsline.com

May 27, 2026

May 24, 2026

TXMD Q3 2023 Earnings: A Significant EPS Miss Amid No Reported RevenueLow Growth Earnings - newsline.com

May 24, 2026

May 22, 2026

TherapeuticsMD (TXMD) Edges Higher as Support Holds Near $2.01Post-Earnings Moves - Newser

May 22, 2026

May 17, 2026

What TherapeuticsMD TXMD flagged as biggest challenges ahead Q3 2023 EPS Misses ViewsBanking Earnings Report - The Legal Advocate

May 17, 2026

May 13, 2026

TherapeuticsMD Announces First Quarter 2026 Financial Results - BioSpace

May 13, 2026

May 13, 2026

TXMD Reports Strong Q1 Revenue Growth and Explores Strategic Alt - GuruFocus

May 13, 2026

May 12, 2026

Is TherapeuticsMD (TXMD) 13.4% Overvalued After Q1 2026 Earnings - GuruFocus

May 12, 2026

May 12, 2026

[10-Q] TherapeuticsMD, Inc. Quarterly Earnings Report - Stock Titan

May 12, 2026

May 12, 2026

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives - TipRanks

May 12, 2026

May 12, 2026

TherapeuticsMD: Q1 Earnings Snapshot - marketscreener.com

May 12, 2026

May 12, 2026

TherapeuticsMD swings to Q1 net income as license revenue rises - TradingView

May 12, 2026

May 12, 2026

TherapeuticsMD (TXMD) details Q1 2026 results and strategic review - Stock Titan

May 12, 2026

May 10, 2026

What TherapeuticsMD (TXMD) flagged as biggest challenges ahead | Q3 2023: EPS Misses ViewsStock Trading Network - Newser

May 10, 2026

May 08, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 08, 2026